Spectrophotometric determination of lisinopril in pharmaceuticals using ninhydrin- a modified approach

An accurate and precise spectrophotometric method is presented for the determination of lisinopril based on the formation of a yellow colour product with ninhydrin in the presence of bicarbonate with an absorption maximum at 420 nm. The reaction proceeds quantitatively at 97±1℃ in 10 min. The calibration curve is linear over the range of 5.0-50.0μg/mL and is described by the regression equation A=(-)0.0175+0.0079 C with a regression coefficient (r) of 0.9979(n=6). The calculated molar absorptivity and Sandell sensitivity values are 2.02×10^3 L/mol/cm and 0.219μg/cm^2, respectively. The limits of detection (LOD) and quantification (LOQ) calculated as per ICH guidelines are 0.68 and 2.07μg/mL, respectively. The within-day accuracy expressed as relative error was better than 2.5% with precision (RSD) ranging from 1.02 to 1.93%. The between-day accuracy ranged from 1.5-3.0% with a precision less than 4%. The method was successfully applied to the analysis of three brands of tablets containing lisinopril. The results obtained were in agreement with those obtained by the BP method. Accuracy was also checked by placebo blank and synthetic mixture analyses besides a recovery study via standard addition procedure. The method was also used to check the stability of lisinopril in solution.

[1]  M. de la Guardia,et al.  Green Analytical Chemistry , 2008 .

[2]  H. Lu London, United Kingdom , 2020, Eco-Cities and Green Transport.

[3]  S. N. Azmi,et al.  Spectrophotometric determination of lisinopril in commercial dosage forms using N-bromosuccinimide and chloranil , 2007 .

[4]  T. Ansari,et al.  Spectrophotometric determination of lisinopril in pure and pharmaceutical formulations , 2005 .

[5]  Manisha Singh,et al.  Optimized and validated spectrophotometric methods for the determination of lisinopril in pharmaceutical formulations using ninhydrin and ascorbic acid , 2005 .

[6]  M. Kashif,et al.  Application of pi-acceptors to the spectrophotometric determination of lisinopril in commercial dosage forms. , 2005, Farmaco.

[7]  R. Reed,et al.  Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulation. , 2005, Journal of pharmaceutical and biomedical analysis.

[8]  Vitor C. Almeida,et al.  Exploiting the bead injection concept for sequential determination of copper and mercury ions in river-water samples. , 2004, Talanta.

[9]  B. Stanisz Estimation of the applicability of differential spectroscopic method for the determination of lisinopril in tablets and for the evaluation of its stability. , 2004, Acta poloniae pharmaceutica.

[10]  G. Theodoridis,et al.  Rapid spectrofluorimetric determination of lisinopril in pharmaceutical tablets using sequential injection analysis , 2004, Analytical and Bioanalytical Chemistry.

[11]  R. Sharma,et al.  Analysis of Trace Amounts of Metal Ions Using Silica-Based Chelating Resins: A Green Analytical Method , 2003 .

[12]  N. Barakat,et al.  Spectrophotometric and polarographic determination of enalapril and lisinopril using 2,4-dinitrofluorobenzene. , 2003, Journal of pharmaceutical and biomedical analysis.

[13]  O. Sagirli,et al.  A new spectrofluorimetric method for the determination of lisinopril in tablets. , 2003, Farmaco.

[14]  F. Belal,et al.  Polarographic Determination of Lisinopril in Pharmaceuticals and Biological Fluids Through Treatment with Nitrous Acid , 2003 .

[15]  M. Koupparis,et al.  Spectrophotometric determination of lisinopril in tablets using 1-fluoro-2,4-dinitrobenzene reagent. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  W. van den Bossche,et al.  Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis. , 2001, Journal of chromatography. A.

[17]  A. El-Gindy,et al.  Spectrophotometric and HPTLC-densitometric determination of lisinopril and hydrochlorothiazide in binary mixtures. , 2001, Journal of pharmaceutical and biomedical analysis.

[18]  H. Senel,et al.  Determination of lisinopril from pharmaceutical preparations by derivative UV spectrophotometry. , 1999, Journal of pharmaceutical and biomedical analysis.

[19]  R. Saha,et al.  Simultaneous Determination of Amlodipine‐Enalapril Maleate and Amlodipine‐Lisinopril in Combined Tablet Preparations by Derivative Spectrophotometry , 1999 .

[20]  R. A. Shaalan,et al.  Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage forms. , 1999, Journal of pharmaceutical and biomedical analysis.

[21]  Sean C. Sweetman,et al.  Martindale: The Complete Drug Reference , 1999 .

[22]  M. Kartal,et al.  Comparison of High - Performance Liquid Chromatography and Absorbance Ratio Methods for the Determination of Hydrochlorothiazide and Lisinopril in Pharmaceutical Formulations , 1999 .

[23]  N. Erk Comparative Study of the Ratio Spectra Derivative Spectrophotometry, Derivative Spectrophotometry and Vierordt's Method Appued to the Analysis of Lisinopril and Hydrochlorothiazide in Tablets , 1998 .

[24]  R. Gotti,et al.  Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). , 1997, Journal of Pharmaceutical and Biomedical Analysis.

[25]  Henderson Ve,et al.  The British Pharmacopoeia. , 1892, British medical journal.